Literature DB >> 23754186

Genetic modifiers in Huntington's disease: fiction or fact?

Larissa Arning1, Jörg T Epplen.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23754186     DOI： 10.1007/s10048-013-0365-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN： 1364-6745            Impact factor:   2.660


× No keyword cloud information.
  10 in total

Review 1.  N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.

Authors:  Mannie M Y Fan; Lynn A Raymond
Journal:  Prog Neurobiol       Date:  2006-12-22       Impact factor: 11.685

Review 2.  Non-replication of association studies: "pseudo-failures" to replicate?

Authors:  Prakash Gorroochurn; Susan E Hodge; Gary A Heiman; Martina Durner; David A Greenberg
Journal:  Genet Med       Date:  2007-06       Impact factor: 8.822

Review 3.  Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function.

Authors:  Clare M Gladding; Lynn A Raymond
Journal:  Mol Cell Neurosci       Date:  2011-05-07       Impact factor: 4.314

4.  The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD.

Authors:  L A Farrer; L A Cupples; P Wiater; P M Conneally; J F Gusella; R H Myers
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

6.  Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Authors:  Eliana Marisa Ramos; Jeanne C Latourelle; Ji-Hyun Lee; Tammy Gillis; Jayalakshmi S Mysore; Ferdinando Squitieri; Alba Di Pardo; Stefano Di Donato; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Karen Marder; James F Gusella; Jong-Min Lee; Isabel Alonso; Jorge Sequeiros; Richard H Myers; Marcy E Macdonald
Journal:  Hum Genet       Date:  2012-07-25       Impact factor: 4.132

7.  Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease.

Authors:  Hong Van B Che; Silke Metzger; Esteban Portal; Carolin Deyle; Olaf Riess; Huu Phuc Nguyen
Journal:  Mol Neurodegener       Date:  2011-01-06       Impact factor: 14.195

8.  The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease.

Authors:  Patrick Weydt; Selma M Soyal; Cinzia Gellera; Stefano Didonato; Claus Weidinger; Hannes Oberkofler; G Bernhard Landwehrmeyer; Wolfgang Patsch
Journal:  Mol Neurodegener       Date:  2009-01-08       Impact factor: 14.195

9.  PGC-1alpha as modifier of onset age in Huntington disease.

Authors:  Elahe Taherzadeh-Fard; Carsten Saft; Jürgen Andrich; Stefan Wieczorek; Larissa Arning
Journal:  Mol Neurodegener       Date:  2009-02-06       Impact factor: 14.195

10.  Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.

Authors:  Eliana Marisa Ramos; Jeanne C Latourelle; Tammy Gillis; Jayalakshmi S Mysore; Ferdinando Squitieri; Alba Di Pardo; Stefano Di Donato; Cinzia Gellera; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; James F Gusella; Jong-Min Lee; Isabel Alonso; Jorge Sequeiros; Richard H Myers; Marcy E Macdonald
Journal:  Neurogenetics       Date:  2013-05-04       Impact factor: 2.660
  10 in total
  1 in total

1.  COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

Authors:  Ruth de Diego-Balaguer; Catherine Schramm; Isabelle Rebeix; Emmanuel Dupoux; Alexandra Durr; Alexis Brice; Perrine Charles; Laurent Cleret de Langavant; Katia Youssov; Christophe Verny; Vincent Damotte; Jean-Philippe Azulay; Cyril Goizet; Clémence Simonin; Christine Tranchant; Patrick Maison; Amandine Rialland; David Schmitz; Charlotte Jacquemot; Bertrand Fontaine; Anne-Catherine Bachoud-Lévi
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.